• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6 受体特异性 RNA 适体用于将货物递送到靶细胞。

Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells.

机构信息

Institute for Biochemistry and Molecular Biology, Chemistry Department, MIN-Faculty, Hamburg University, Hamburg, Germany.

出版信息

RNA Biol. 2012 Jan;9(1):67-80. doi: 10.4161/rna.9.1.18062. Epub 2012 Jan 1.

DOI:10.4161/rna.9.1.18062
PMID:22258147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3342945/
Abstract

Aptamers represent an emerging strategy to deliver cargo molecules, including dyes, drugs, proteins or even genes, into specific target cells. Upon binding to specific cell surface receptors aptamers can be internalized, for example by macropinocytosis or receptor mediated endocytosis. Here we report the in vitro selection and characterization of RNA aptamers with high affinity (Kd = 20 nM) and specificity for the human IL-6 receptor (IL-6R). Importantly, these aptamers trigger uptake without compromising the interaction of IL-6R with its natural ligands the cytokine IL-6 and glycoprotein 130 (gp130). We further optimized the aptamers to obtain a shortened, only 19-nt RNA oligonucleotide retaining all necessary characteristics for high affinity and selective recognition of IL-6R on cell surfaces. Upon incubation with IL-6R presenting cells this aptamer was rapidly internalized. Importantly, we could use our aptamer, to deliver bulky cargos, exemplified by fluorescently labeled streptavidin, into IL-6R presenting cells, thereby setting the stage for an aptamer-mediated escort of drug molecules to diseased cell populations or tissues.

摘要

适配体代表了一种将货物分子(包括染料、药物、蛋白质甚至基因)递送到特定靶细胞的新兴策略。与特定的细胞表面受体结合后,适配体可以被内化,例如通过巨胞饮作用或受体介导的内吞作用。在这里,我们报告了对人类白细胞介素 6 受体(IL-6R)具有高亲和力(Kd = 20 nM)和特异性的 RNA 适配体的体外选择和特性。重要的是,这些适配体在不影响 IL-6R 与其天然配体细胞因子白细胞介素 6(IL-6)和糖蛋白 130(gp130)相互作用的情况下触发摄取。我们进一步优化了适配体,获得了一个缩短的、只有 19 个核苷酸的 RNA 寡核苷酸,保留了高亲和力和选择性识别细胞表面 IL-6R 的所有必要特征。与表达 IL-6R 的细胞孵育后,该适配体迅速被内化。重要的是,我们可以使用我们的适配体将大体积的货物,例如荧光标记的链霉亲和素,递送到表达 IL-6R 的细胞中,从而为药物分子通过适配体介导递送到疾病细胞群或组织奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/087cbf885b98/rna-9-67-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/0643d611a614/rna-9-67-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/a3b89565aa5a/rna-9-67-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/4c6dc4616318/rna-9-67-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/3db692297275/rna-9-67-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/bc63b3c170f9/rna-9-67-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/419df9fd4159/rna-9-67-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/fe3390a00696/rna-9-67-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/0247c39df19f/rna-9-67-g8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/63b415ee3c1e/rna-9-67-g9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/087cbf885b98/rna-9-67-g10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/0643d611a614/rna-9-67-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/a3b89565aa5a/rna-9-67-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/4c6dc4616318/rna-9-67-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/3db692297275/rna-9-67-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/bc63b3c170f9/rna-9-67-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/419df9fd4159/rna-9-67-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/fe3390a00696/rna-9-67-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/0247c39df19f/rna-9-67-g8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/63b415ee3c1e/rna-9-67-g9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b486/3342945/087cbf885b98/rna-9-67-g10.jpg

相似文献

1
Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells.白细胞介素-6 受体特异性 RNA 适体用于将货物递送到靶细胞。
RNA Biol. 2012 Jan;9(1):67-80. doi: 10.4161/rna.9.1.18062. Epub 2012 Jan 1.
2
RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.RAID3——一种具有抗选择后修饰亲和力的白细胞介素-6受体结合适体。
RNA Biol. 2015;12(9):1043-53. doi: 10.1080/15476286.2015.1079681.
3
Stabilized Interleukin-6 receptor binding RNA aptamers.稳定的白细胞介素-6受体结合RNA适配体。
RNA Biol. 2014;11(1):57-65. doi: 10.4161/rna.27447. Epub 2013 Dec 20.
4
In vitro selection of an RNA aptamer yields an interleukin-6/interleukin-6 receptor interaction inhibitor.体外筛选 RNA 适体得到白细胞介素 6/白细胞介素 6 受体相互作用抑制剂。
Biosci Biotechnol Biochem. 2021 Apr 24;85(5):1170-1174. doi: 10.1093/bbb/zbaa124.
5
Charomers-Interleukin-6 Receptor Specific Aptamers for Cellular Internalization and Targeted Drug Delivery.用于细胞内化和靶向药物递送的 Charomers-白细胞介素 6 受体特异性适体。
Int J Mol Sci. 2017 Dec 6;18(12):2641. doi: 10.3390/ijms18122641.
6
Interleukin-6 controls recycling and degradation, but not internalization of its receptors.白细胞介素-6 控制其受体的循环和降解,但不控制其内化。
J Biol Chem. 2021 Jan-Jun;296:100434. doi: 10.1016/j.jbc.2021.100434. Epub 2021 Feb 19.
7
SELEX of Cell-Specific RNA Aptamers.细胞特异性RNA适配体的指数富集配体系统进化技术
Methods Mol Biol. 2016;1380:21-32. doi: 10.1007/978-1-4939-3197-2_2.
8
Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor.解析病毒白细胞介素-6与gp130的结合以及白细胞介素-6受体非依赖性STAT信号通路的激活。
J Virol. 2009 May;83(10):5117-26. doi: 10.1128/JVI.01601-08. Epub 2009 Mar 4.
9
The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).睫状神经营养因子(CNTF)中的氨基酸替换 R28E 可消除白细胞介素-6 受体依赖性,但通过糖蛋白 130(gp130)/白血病抑制因子受体(LIFR)保留 CNTF 受体依赖性信号转导。
J Biol Chem. 2014 Jun 27;289(26):18442-50. doi: 10.1074/jbc.M114.568857. Epub 2014 May 6.
10
Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor.化学修饰的 DNA 适体与白细胞介素-6 具有高亲和力,并通过阻断其与白细胞介素-6 受体的相互作用来抑制信号转导。
J Biol Chem. 2014 Mar 21;289(12):8706-19. doi: 10.1074/jbc.M113.532580. Epub 2014 Jan 12.

引用本文的文献

1
Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers.基于抗体和适配体的骨关节炎治疗方法:抗体的应用及适配体的前景。
Mol Ther Nucleic Acids. 2025 May 5;36(2):102552. doi: 10.1016/j.omtn.2025.102552. eCollection 2025 Jun 10.
2
Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases.适配体作为衰老及衰老相关疾病的诊断和治疗剂
Biosensors (Basel). 2025 Apr 5;15(4):232. doi: 10.3390/bios15040232.
3
Evolution of a bispecific G-quadruplex-forming circular aptamer to block IL-6/sIL-6R interaction for inflammation inhibition.

本文引用的文献

1
Structural and catalytic roles of metal ions in RNA.金属离子在RNA中的结构和催化作用。
Met Ions Life Sci. 2011;9:vii-ix.
2
Cell-specific aptamers as emerging therapeutics.细胞特异性适配体作为新兴疗法。
J Nucleic Acids. 2011;2011:904750. doi: 10.4061/2011/904750. Epub 2011 Aug 28.
3
Intracellular delivery of RNA-based therapeutics using aptamers.使用适配体进行基于RNA的治疗药物的细胞内递送。
一种双特异性形成G-四链体的环状适体的进化,以阻断IL-6/sIL-6R相互作用来抑制炎症。
Chem Sci. 2024 Jul 17;15(32):13011-13020. doi: 10.1039/d4sc02183e. eCollection 2024 Aug 14.
4
Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery.受体介导的肿瘤靶向药物递送研究进展
Adv Ther (Weinh). 2019 Jan;2(1). doi: 10.1002/adtp.201800091. Epub 2018 Sep 10.
5
Anti-cancer activity of ultra-short single-stranded polydeoxyribonucleotides.超短单链聚脱氧核糖核苷酸的抗癌活性
Invest New Drugs. 2023 Feb;41(1):153-161. doi: 10.1007/s10637-023-01333-y. Epub 2023 Feb 7.
6
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers.适体核苷酸类似物药物偶联物在癌症靶向治疗中的应用
Front Cell Dev Biol. 2022 Dec 5;10:1053984. doi: 10.3389/fcell.2022.1053984. eCollection 2022.
7
Aptamer‑based therapy for targeting key mediators of cancer metastasis (Review).基于适配体的癌症转移关键介质靶向治疗(综述)
Int J Oncol. 2022 Jun;60(6). doi: 10.3892/ijo.2022.5355. Epub 2022 Apr 15.
8
Cancer immunomodulation using bispecific aptamers.使用双特异性适体进行癌症免疫调节。
Mol Ther Nucleic Acids. 2022 Jan 10;27:894-915. doi: 10.1016/j.omtn.2022.01.008. eCollection 2022 Mar 8.
9
Aptamer-based biosensors for the diagnosis of sepsis.基于适配体的用于脓毒症诊断的生物传感器。
J Nanobiotechnology. 2021 Jul 19;19(1):216. doi: 10.1186/s12951-021-00959-5.
10
Recent Progress and Opportunities for Nucleic Acid Aptamers.核酸适体的最新进展与机遇
Life (Basel). 2021 Feb 28;11(3):193. doi: 10.3390/life11030193.
Ther Deliv. 2010 Dec;1(6):849-61. doi: 10.4155/tde.10.61.
4
Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.在溃疡性结肠炎的小鼠模型中,肿瘤的发展依赖于结肠 F4/80+CD11b(高)Gr1(低)巨噬细胞的 MyD88 信号转导。
J Clin Invest. 2011 May;121(5):1692-708. doi: 10.1172/JCI42540. Epub 2011 Apr 25.
5
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.白细胞介素 6 转染信号通过 Stat3/Socs3 的激活促进胰腺上皮内瘤变的进展和胰腺癌的发生。
Cancer Cell. 2011 Apr 12;19(4):456-69. doi: 10.1016/j.ccr.2011.03.009.
6
IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis.IL-17RA 适体介导的 IL-6 抑制抑制骨关节炎小鼠模型中的滑膜炎症。
Osteoarthritis Cartilage. 2011 Jun;19(6):711-8. doi: 10.1016/j.joca.2011.01.018. Epub 2011 Feb 22.
7
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.靶向递送顺铂前药用于体内更安全、更有效的前列腺癌治疗。
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1850-5. doi: 10.1073/pnas.1011379108. Epub 2011 Jan 13.
8
Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.鉴定针对 E-选择素的硫代适配体配体:针对炎症血管靶向的潜在应用。
PLoS One. 2010 Sep 30;5(9):e13050. doi: 10.1371/journal.pone.0013050.
9
A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.适体治疗 AS1411 作用的新范例:通过巨胞饮作用摄取及其受核仁素依赖性机制的刺激。
Cancer Res. 2010 Nov 1;70(21):8617-29. doi: 10.1158/0008-5472.CAN-10-0920. Epub 2010 Sep 21.
10
A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer.载药适体-金纳米粒子生物缀合物用于前列腺癌的联合 CT 成像与治疗。
ACS Nano. 2010 Jul 27;4(7):3689-96. doi: 10.1021/nn901877h.